Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials (Q1654244)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials |
scientific article; zbMATH DE number 6914542
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials |
scientific article; zbMATH DE number 6914542 |
Statements
Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials (English)
0 references
7 August 2018
0 references
area under the concentration curve
0 references
continuation ratio model
0 references
\(D\)-optimum sampling times
0 references
one-compartment pharmacokinetic model
0 references
population pharmacokinetics
0 references
0 references
0.86831415
0 references
0.8666593
0 references
0.86332417
0 references
0.86031216
0 references
0 references
0.85379446
0 references
0.85189974
0 references
0.84894913
0 references
